John Coleman
Directeur/Bestuurslid bij KANE BIOTECH INC.
Profiel
John Coleman is the founder of Anandia Laboratories, Inc., which was founded in 2013.
He held the title of President & Chief Operating Officer from 2018 to 2021.
Dr. Coleman is currently the President & Chief Executive Officer at Avivo Biomedical, Inc. since 2022 and a Director at Kane Biotech, Inc. since 2023.
He previously worked as the Vice President-Business Development at Delic Holdings Corp.
in 2021.
Dr. Coleman obtained a doctorate degree from the University of British Columbia in 1997 and an undergraduate degree from Bishop's University in 1992.
Actieve functies van John Coleman
Bedrijven | Functie | Begin |
---|---|---|
KANE BIOTECH INC. | Directeur/Bestuurslid | 16-11-2023 |
Eerdere bekende functies van John Coleman
Bedrijven | Functie | Einde |
---|---|---|
DELIC HOLDINGS CORP. | Corporate Officer/Principal | 01-09-2021 |
Anandia Laboratories, Inc.
Anandia Laboratories, Inc. BiotechnologyHealth Technology Anandia Laboratories, Inc. operates as a cannabis biotechnology firm. It also offers analytical testing services including potency, pesticides, microbes, and terpenes to licensed producers and patients. The company was founded by Jonathan Page and John Coleman on November 26, 2013 and is headquartered in Vancouver, Canada. | Oprichter | 16-03-2021 |
Opleiding van John Coleman
University of British Columbia | Doctorate Degree |
Bishop's University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DELIC HOLDINGS CORP. | Technology Services |
KANE BIOTECH INC. | Commercial Services |
Bedrijven in privébezit | 1 |
---|---|
Anandia Laboratories, Inc.
Anandia Laboratories, Inc. BiotechnologyHealth Technology Anandia Laboratories, Inc. operates as a cannabis biotechnology firm. It also offers analytical testing services including potency, pesticides, microbes, and terpenes to licensed producers and patients. The company was founded by Jonathan Page and John Coleman on November 26, 2013 and is headquartered in Vancouver, Canada. | Health Technology |